BioNexus Gene Lab (BGLC) Deferred Taxes (2022 - 2023)
BioNexus Gene Lab's (BGLC) quarterly Deferred Taxes came in at $15990.0 in Q2 2023, up 886.43% year-over-year from $1621.0 in Q2 2022, and up 886.43% quarter-over-quarter from $1621.0 in Q2 2022.
Powered by 
Analysis
BioNexus Gene Lab (BGLC) Deferred Taxes (2022 - 2023) Analysis & Trends
BioNexus Gene Lab has disclosed Deferred Taxes across 2 years of filings, most recently posting $15990.0 for Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | W.W. Grainger | 59.81 Bn | 59.22 Bn | 1.98 Bn | 23.00 Mn |
| 2 | Fastenal | 55.76 Bn | 55.56 Bn | 1.06 Bn | 200,000.00 |
| 3 | Ferguson Enterprises | 42.93 Bn | 42.11 Bn | 2.32 Bn | -38.00 Mn |
| 4 | Reliance | 19.94 Bn | 19.70 Bn | 1.30 Bn | - |
| 5 | Wesco International | 16.86 Bn | 16.06 Bn | 1.46 Bn | -13.10 Mn |
| 6 | Applied Industrial Technologies | 11.85 Bn | 11.72 Bn | 411.22 Mn | - |
| 7 | Watsco | 11.80 Bn | 11.33 Bn | 578.93 Mn | - |
| 8 | Avantor | 9.95 Bn | 9.64 Bn | 537.00 Mn | 16.30 Mn |
| 9 | Core & Main | 7.66 Bn | 7.51 Bn | 520.00 Mn | -6.00 Mn |
| 10 | BioNexus Gene Lab | 2.60 Mn | -922,180.04 | 12,982.00 | - |